🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To compare the bacteriological eradication rates of Finafloxacin and Ciprof...
Status
Completed
Location
Medical practice, Dr. J. Hein (Principal Study Investigator)
Start Date
2008-10
Trial ID
NCT00722735
Treatments Being Tested
This study investigates the safety, tolerability, and PK profile of finaflo...
Status
Completed
Location
Pulmonary Associates, PA
Start Date
2012-01
Trial ID
NCT01907867
Treatments Being Tested
The primary objective of this study is to evaluate the microbiological and ...
Status
Completed
Location
Universitätsklinikum Giessen, Klinik für Urologie, Kinderurologie und Andrologie
Start Date
2012-12
Trial ID
NCT01928433
Treatments Being Tested
This is the first time finafloxacin was administered to humans intravenousl...
Status
Completed
Location
Covance Clinical Research Unit Ltd
Start Date
2010-09
Trial ID
NCT01910883
The primary objective of this study is to compare the H. pylori eradication...
Status
Completed
Location
Dr. Hein
Start Date
2008-09
Trial ID
NCT00723502
Treatments Being Tested
Previous clinical studies have indicated that finafloxacin is well-tolerate...
Status
Completed
Location
Celerion (formerly MDS Pharmaservices)
Start Date
2010-02
Trial ID
NCT01904162
Treatments Being Tested
The purpose of this study is to study the safety of single doses and multip...
Status
Completed
Location
Swiss Pharma Contract Ltd
Start Date
2007-08
Trial ID
NCT00483158
Treatments Being Tested